Akeso, Inc.

SEHK:9926 Stock Report

Market Cap: HK$104.5b

Akeso Management

Management criteria checks 4/4

Akeso's CEO is Michelle Xia, appointed in Mar 2012, has a tenure of 13.67 years. total yearly compensation is CN¥5.55M, comprised of 85.4% salary and 14.6% bonuses, including company stock and options. directly owns 8.15% of the company’s shares, worth HK$8.88B. The average tenure of the management team and the board of directors is 3.3 years and 6 years respectively.

Key information

Michelle Xia

Chief executive officer

CN¥5.5m

Total compensation

CEO salary percentage85.40%
CEO tenure13.7yrs
CEO ownership8.2%
Management average tenure3.3yrs
Board average tenure6yrs

Recent management updates

Here's Why Akeso, Inc.'s (HKG:9926) CEO May Deserve A Raise

Jun 23
Here's Why Akeso, Inc.'s (HKG:9926) CEO May Deserve A Raise

Recent updates

Akeso, Inc.'s (HKG:9926) Intrinsic Value Is Potentially 74% Above Its Share Price

Oct 28
Akeso, Inc.'s (HKG:9926) Intrinsic Value Is Potentially 74% Above Its Share Price

Akeso, Inc. (HKG:9926) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Sep 22
Akeso, Inc. (HKG:9926) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

What Akeso, Inc.'s (HKG:9926) 31% Share Price Gain Is Not Telling You

Jul 03
What Akeso, Inc.'s (HKG:9926) 31% Share Price Gain Is Not Telling You

Here's Why Akeso, Inc.'s (HKG:9926) CEO May Deserve A Raise

Jun 23
Here's Why Akeso, Inc.'s (HKG:9926) CEO May Deserve A Raise

Akeso, Inc.'s (HKG:9926) Shares Climb 29% But Its Business Is Yet to Catch Up

May 07
Akeso, Inc.'s (HKG:9926) Shares Climb 29% But Its Business Is Yet to Catch Up

Earnings Update: Here's Why Analysts Just Lifted Their Akeso, Inc. (HKG:9926) Price Target To HK$104

May 03
Earnings Update: Here's Why Analysts Just Lifted Their Akeso, Inc. (HKG:9926) Price Target To HK$104
User avatar

Cadonilimab And Ivonescimab Trials Will Broaden Market Access

Akeso's strategic focus on bispecific antibodies and NRDL inclusion could drive significant revenue growth and expand market access.

Earnings Update: Here's Why Analysts Just Lifted Their Akeso, Inc. (HKG:9926) Price Target To HK$82.91

Apr 01
Earnings Update: Here's Why Analysts Just Lifted Their Akeso, Inc. (HKG:9926) Price Target To HK$82.91

Akeso, Inc.'s (HKG:9926) Shares Climb 28% But Its Business Is Yet to Catch Up

Mar 16
Akeso, Inc.'s (HKG:9926) Shares Climb 28% But Its Business Is Yet to Catch Up

CEO Compensation Analysis

How has Michelle Xia's remuneration changed compared to Akeso's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-CN¥846m

Mar 31 2025n/an/a

-CN¥680m

Dec 31 2024CN¥6mCN¥5m

-CN¥515m

Sep 30 2024n/an/a

-CN¥625m

Jun 30 2024n/an/a

-CN¥735m

Mar 31 2024n/an/a

CN¥646m

Dec 31 2023CN¥7mCN¥4m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥409m

Dec 31 2022CN¥5mCN¥4m

-CN¥1b

Sep 30 2022n/an/a

-CN¥1b

Jun 30 2022n/an/a

-CN¥1b

Mar 31 2022n/an/a

-CN¥1b

Dec 31 2021CN¥7mCN¥4m

-CN¥1b

Sep 30 2021n/an/a

-CN¥1b

Jun 30 2021n/an/a

-CN¥929m

Mar 31 2021n/an/a

-CN¥983m

Dec 31 2020CN¥7mCN¥3m

-CN¥1b

Sep 30 2020n/an/a

-CN¥870m

Jun 30 2020n/an/a

-CN¥703m

Mar 31 2020n/an/a

-CN¥492m

Dec 31 2019CN¥2mCN¥1m

-CN¥282m

Compensation vs Market: Michelle's total compensation ($USD779.06K) is about average for companies of similar size in the Hong Kong market ($USD682.13K).

Compensation vs Earnings: Michelle's compensation has been consistent with company performance over the past year.

CEO

Michelle Xia (58 yo)

13.7yrs
Tenure
CN¥5,548,000
Compensation

Dr. Yu Xia, Ph D., also known as Michelle, is CEO & President of Akeso Biopharma, Inc. Dr. Xia is Founder of Akeso, Inc. Dr. Xia is CEO, President & Chairwoman of Akeso, Inc. from March 19, 2012. She has b...

Leadership Team

NamePositionTenureCompensationOwnership
Yu Xia
Founder13.7yrsCN¥5.55m8.15%
HK$ 8.5b
Baiyong Li
Co-Founder13.7yrsCN¥5.28m5.34%
HK$ 5.6b
Zhongmin Wang
Co-Founderno dataCN¥3.96m4.65%
HK$ 4.9b
Peng Zhang
Co-Founderno dataCN¥3.83mno data
Yu Xia
Senior Vice President1.1yrsCN¥9.33mno data
Bing Wang
Chief Financial Officer1.3yrsno datano data
Mingxiu Hu
Senior Vice President3.8yrsno datano data
Xinfeng Zhang
Senior Vice President5.3yrsno datano data
Jing Min
Senior Vice President2.8yrsno datano data
Yong Guo
Senior VP & Chief Commercial Officer1.8yrsno datano data
Wai Yan Leung
Company Secretary3.3yrsno datano data
3.3yrs
Average Tenure
56yo
Average Age

Experienced Management: 9926's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yu Xia
Founder13.7yrsCN¥5.55m8.15%
HK$ 8.5b
Baiyong Li
Co-Founder6yrsCN¥5.28m5.34%
HK$ 5.6b
Zhongmin Wang
Co-Founder6yrsCN¥3.96m4.65%
HK$ 4.9b
Peng Zhang
Co-Founder1.4yrsCN¥3.83mno data
Bo Tan
Independent Non-Executive Directorno dataCN¥320.00kno data
Ronggang Xie
Non-Executive Director5.3yrsno datano data
Yan Xu
Independent Non-Executive Directorno dataCN¥320.00kno data
Junwen Zeng
Independent Non-Executive Directorno dataCN¥320.00kno data
6.0yrs
Average Tenure
56yo
Average Age

Experienced Board: 9926's board of directors are considered experienced (6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/03 15:40
End of Day Share Price 2025/11/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Akeso, Inc. is covered by 40 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shun Kei LawCCB International Securities Limited
Zhishun SiuCCB International Securities Limited
Lily WangCGS International